Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simulect in steroid-refractory ulcerative colitis
NCT00430898Phase 2Completed
- Sponsor
- Cerimon Pharmaceuticals, Inc.
- Start
- Jan 2007
- Primary completion
- Sep 2008
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 2 trial of basiliximab in ulcerative colitis (UC), sponsored by Cerimon Pharmaceuticals, Inc.. Started Jan 2007; status: completed.
02
Drugs
basiliximab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00430898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430898.